Arrow Financial AROW Shares issued under the Directors’ Stock Plan

Shares issued under the Directors’ Stock Plan at other companies

Tarsus Pharmaceuticals, Inc.TARS

$5.54M+4.1%

Cboe Global MarketsCBOE

$5M+4.2%

Orrstown Financial ServicesORRF

$665K—

Orrstown Financial ServicesORRF

665K—

BioCryst PharmaceuticalsBCRX

$45K+32.4%

BioCryst PharmaceuticalsBCRX

45K+32.4%

FAQ

What is Arrow Financial's shares issued under the directors’ stock plan?

Arrow Financial (AROW) reported shares issued under the directors’ stock plan of $116K in Q2 2026.

How has Arrow Financial's shares issued under the directors’ stock plan changed year-over-year?

Arrow Financial's shares issued under the directors’ stock plan decreased by 2.5% year-over-year, from $119K to $116K.

What is the long-term trend for Arrow Financial's shares issued under the directors’ stock plan?

Over 3 years (2021 to 2025), Arrow Financial's shares issued under the directors’ stock plan has grown at a 6.6% compound annual growth rate (CAGR), from $376K to $455K.

What does shares issued under the directors’ stock plan mean?

This represents cash received from the issuance of company stock to directors or employees under specific compensation plans. It reflects the equity-based incentive structure and the extent to which internal stakeholders participate in ownership. This metric helps investors track dilution and the alignment of management interests with shareholders.